Market Cap

GuiZhou SanLi Pharmaceutical Co. Ltd Market Capitalization:

CN¥4.83 Billion

CNY as of Jan. 1, 2026

US$687.8 Million

business GuiZhou SanLi Pharmaceutical Co. Ltd Company Profile

GuiZhou SanLi Pharmaceutical Co. Ltd Main Stock Listing

SSE: 603439

Market Capitalization History of GuiZhou SanLi Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of GuiZhou SanLi Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 CN¥4.83 B -7.65%
Jan. 1, 2025 CN¥5.22 B -33.88%
Jan. 1, 2024 CN¥7.90 B 30.98%
Jan. 1, 2023 CN¥6.03 B 11.78%
Jan. 1, 2022 CN¥5.40 B -17.87%
Jan. 1, 2021 CN¥6.57 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

GuiZhou SanLi Pharmaceutical Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

GuiZhou SanLi Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603439

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.